Immune Suppression Of Infants Treated With Steroids

Completed

Conditions studied: Hemangioma

In brief

The goal of this study is to clarify the degree of immune suppression in infants requiring therapy and to create guidelines for evaluation and prevention of infection in infants on oral steroids for hemangiomas.

Key facts

Study ID

NCT00433940

Run by

Medical College of Wisconsin

People needed

16

Starts

2006-10-01

Expected to finish

2010-07-01

Last updated by the study team

2013-01-24

Who can join

Age: any, up to 1. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Infants < 6 months of age with infantile hemangiomas requiring treatment with oral corticosteroids
• Infant must be enrolled prior to initiation of steroid therapy

You may not qualify if…

• Infants > 6 months of age
• Infants already receiving oral corticosteroid treatment prior to the start of this study
• Infants with know immunodeficiencies
• Infants receiving other oral medications for the treatment of hemangiomas

Where it is running

• Children's Hospital of Wisconsin — Milwaukee, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.